Latest articles
Pharmazoomer #4 – Local production deals, GLP-1 pills, moves in Morocco…
In this fourth edition of Pharmazoomer, get the latest news on local production agreements, GLP-1…
Pharma perspective – Towards a Saudization of pharmacy.
In January 2025, the Minister of Human Resources and Social Development issued a resolution to…
Where are we on LCGPA agreements in Saudi Arabia?
Vision 2030 sets an ambitious plan to localize medicines and vaccines in Saudi Arabia. Where…
Egypt: the quest to become an API hub
We saw in our recent articles that supply chain disruptions force countries to redefine their…
Is Saudi Arabia on the path of self-suficiency?
The Public Investment Fund (PIF) has established its Vision 2030 to enable Saudi Arabia’s private…
Insulin supply and localization of production: Malaysia’s case.
103 years after its discovery, insulin is reinventing itself: from pricing readjustments in major markets…
Free reports
Saudi Arabia Q3 2024
In this report you will find an exclusive report on Saudi Arabia’s path to self-sufficiency.
News on top Saudi players: Tabuk, Avalon, and Jamjoom… and global pharma players.
You will also find the notable market authorizations in this market!
Malaysia Q3 2024
In this report, you will find an exclusive article on localization forces driving the insulin market in Malaysia. The competitive landscape: Biocon, Pharmaniaga, GSK, Novo Nordisk… what these companies have been up to in Q3?
Get also an overview on recent market approvals.
